[{"from": "human", "value": "Provide a brief overview of this molecule. [C][C][=Branch2][Ring2][N][=C][Branch2][Ring2][Ring1][N][C@H1][Branch1][Ring2][S][Ring1][=Branch1][C@@H1][Branch1][Branch1][C][Ring1][Branch1][=O][N][C][=Branch1][C][=O][C@@H1][Branch1][N][C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][O][N][C][=Branch1][C][=O][O][C][S][C][=N][N][N][=C][Ring1][Branch1]"}, {"from": "gpt", "value": "The molecule is a cephalosporin compound having (1H-1,2,3-triazol-4-ylsulfanyl)methyl and [(2R)-2-amino-2-(4-hydroxyphenyl)]acetamido side-groups. An antibacterial drug first prepared in the 1970s, it has more recently been found to be an inhibitor of eukaryotic elongation factor-2 kinase (eEF2K), which is known to regulate apoptosis, autophagy and ER stress in many types of human cancers. It has a role as an antibacterial drug and an EC 2.7.11.20 (elongation factor 2 kinase) inhibitor. It is a cephalosporin, a semisynthetic derivative, a carboxylic acid, a member of triazoles, a member of phenols and an amino acid amide."}]